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PRISONS AND HEALTH
Who cares about healthcare transitions in prisoners
with mental health problems?
Laavanya Damodaran registrar in psychiatry 1, Joe Reilly professor of psychiatry, University of
Durham 2
1Tees Esk and Wear Valley NHS Foundation Trust, Darlington, UK; 2Wolfson Research Institute, Queen’s Campus, Stockton TS17 6BH, UK
WewelcomeGinn’s inclusion of mental health as a key element
in the challenges of prison healthcare.1 Up to 90% of prisoners
have a diagnosable mental illness, personality disorder, or
substance misuse disorder,2 and many will have been difficult
to engage outside prison. Continuity of treatment from
community to prison might be assumed to be a basic element
of good prison mental healthcare.
However, this seems not to be the case. Two thirds of prisoners
received into custody with current prescriptions of psychotropic
drugs did not receive that treatment during the first month.3 This
puts those with established mental illness at risk of relapse and
affects their progress during their sentence. Abrupt
discontinuation with no clear rationale may be the norm rather
than the exception, even for antipsychotics, with risk, mistrust,
role conflict, and poor information sharing systems as underlying
factors.4This complicates the process of continuing prescriptions
for those who genuinely need psychotropic drugs. One of us
(LD) has come across situations where offenders transferred
between prisons have not been continued on their existing
psychotropic drug prescribed in the previous institution.
We wonder whether this discontinuity at a crucial transition
applies to long term physical conditions too. Transitions of care
are known to be difficult, even when there is goodwill to manage
themwell, as in child to adult transitions in mental health. More
effort should be brought to bear on transitions for one of our
most disadvantaged groups—prisoners with severemental health
problems.
Competing interests: None declared.
1 Ginn S. Prison environment and health. BMJ 2012;345:e5921. (17 September.)
2 Singleton N, Meltzer H, Gatward R. Psychiatric morbidity among prisoners in England
and Wales. Stationery Office, 1998.
3 Shaw J, Senior J, Hayes A, Davies L, Appleby L, Rogers A, et al. Evaluation of the care
of at risk prisoners project. University of Manchester, 2006.
4 Hassan L, Senior J, Edge D, Shaw J. Continuity of supply of psychiatric medicines for
newly received prisoners. The Psychiatrist 2011;35:244-5.
Cite this as: BMJ 2012;345:e6760
© BMJ Publishing Group Ltd 2012
l.damodaran@nhs.net
For personal use only: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;345:e6760 doi: 10.1136/bmj.e6760 (Published 9 October 2012) Page 1 of 1
Letters
LETTERS
